Eiger Biopharmaceuticals Inc buy Reibach111
Start price
23.07.17
/
50%
€8.79
Target price
11.01.18
€13.53
Performance (%)
53.85%
End price
11.01.18
€13.53
Summary
This prediction ended on 11.01.18 with a price of €13.53. With a performance of 53.85% the BUY prediction by Reibach111 was a big success. Reibach111 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Eiger Biopharmaceuticals Inc | - | - | - | - |
| iShares Core DAX® | -0,87 % | 5,32 % | 6,86 % | 65,21 % |
| iShares Nasdaq 100 | -0,38 % | 1,98 % | 25,70 % | 90,33 % |
| iShares Nikkei 225® | -1,68 % | 1,95 % | 41,44 % | 80,62 % |
| iShares S&P 500 | -0,65 % | 2,07 % | 21,40 % | 70,74 % |
Comments by Reibach111 for this prediction
In the thread Eiger Biopharmaceuticals Inc diskutieren
Reibach111 stimmt dem Crowdsentiment von 'Buy' zu
Reibach111 stimmt am 23.07.2017 dem Buy-Crowdsentiment mit dem Kursziel 13.3$ zu.
(Zielkurs erreicht)


